reduced functional capacity 4, 5 and increased risk for cardiovascular morbidity and mortality. 6, 7 Peripheral arterial disease affects some 12% to 14% of the general population. The prevalence of peripheral arterial disease is age-dependent, reaching 10% in people aged over 60 years 8, 9 , and some 20% aged over 75 years10-12. Peripheral vascular disease is estimated to affect some 27 million people in Europe and North America. 13 Despite its widespread prevalence and negative associations with quality of life, morbidity, and mortality, PAD remains under diagnosed and undertreated. 3, 15, 16 Preventable or treatable risk factors for PAD are generally thought to mirror other forms of cardiovascular disease and include tobacco (both smoker and smokeless) user, type 2 diabetes, and clinically elevated levels of blood pressure and cholesterol, which are the main therapeutic targets in clinical and prevention guidelines. 17, 18 However, their respective associations with risk of PAD and the extent to which they are jointly associated with the incidence of PAD are not well established.
Peripheral arterial disease is considered to be a set of chronic or acute syndromes, generally derived from the presence of occlusive arterial disease, which cause inadequate blood flow to the limbs. On most occasions, the underlying disease process is arteriosclerotic disease, mainly affecting the revascularization to the lower limbs; From the physiologic point of view, ischemia of the lower limbs can be classified as functional or critical. Functional ischemia occurs when the blood flow is normal at rest but insufficient during exercise, presenting clinically as intermittent claudication. Critical ischemia is produced when the reduction in blood flow results in a perfusion deficit at rest and is defined by the presence of pain at rest or trophic lesions in the legs. In this situation, precise diagnosis is fundamental, as there exists a clear risk of loss of the limb if adequate blood flow is not reestablished, either by surgery or by endovascular therapy. Differentiating between the two concepts is important in order to establish the therapeutic indication and the prognosis in patients with PAD. The degree of clinical involvement depends on two factors: the chronologic evolution of the process (acute or chronic) and the localization, and extension of the disease (involvement of 1 or more sectors). 19 Tobacco is the most important, preventable risk factor for PAD. Smoker has a significantly greater risk of developing PAD than people who have never smoked. Some types of peripheral arterial disease are almost exclusively found in tobacco user. Tobacco smoking currently kills five million people a year worldwide and, according to estimates, will probably kill eight million people a year between now and 2030 and one billion over the course of the 21 st century. 20, 21 The World Health Organization projects that the number of smokers worldwide will increase from 1.3 billion today to about 1.7 billion in 2025. In 2010, the World Health Organization (WHO) chose as the theme of "World No Tobacco Day" the relation between gender and tobacco, with an emphasis on marketing cigarettes to women. This theme was chosen "to draw particular attention to the harmful effects of tobacco marketing towards women and girls". 22 In Bangladesh, tobacco use has become not only a major contributor to the country's high morbidity, but also the biggest drains to the nation's economy. Several national studies in Bangladesh have shown high prevalence of both smoking (e.g., cigarettes, bidis) and use of smokeless tobacco (e.g., betel quid with tobacco, khoini, gul, zarda). 23 
Methodology

Study population and design
This prospective observational study was conducted in the Department of Cardiology, Ibrahim Cardiac Hospital & Research Institute, Dhaka for a period of 4 months starting from January, 2016 to April, 2016. A total of 60 patients who were presented with chest pain and diabetic with and without tobacco user followed up during hospital period. Patients were categorized into two groups on the basis of tobacco use. Group I (diabetic with tobacco user) had 30 patients and Group II (diabetic without tobacco user) had 30 patients.
Ankle Brachial Index
The ankle-brachial pressure index (ABPI) or anklebrachial index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachium). Compared to the arm, lower blood pressure in the leg is an indication of blocked arteries due to peripheral artery disease (PAD). The ABPI is calculated by dividing the systolic blood pressure at the ankle by the systolic blood pressure in the arm. 24 Where P Leg is the systolic blood pressure of dorsalis pedis or posterior tibial arteries And P Arm is the highest of the left and right arm brachial systolic blood pressure
The ABPI test is a popular tool for the non-invasive assessment of PVD. Studies have shown the sensitivity of ABPI is 90% with a corresponding 98% specificity for detecting hemodynamically significant (Serious) stenosis>50% in major leg arteries, defined by angiogram. 25 ABPI value of under 0.50, is considered as severe arterial disease. 26 
Statistical Analysis
The age and gender differences and hypertension, diabetes, dyslipidaemia, smoking habit, family history of IHD, CKD, peripheral artery and coronary artery profile were statistically analyzed. Influence of these parameter with standard deviation (SD) was investigated. Data were entered in computer using SPSS for windows version 16.0 (SPSS Inc., Chicago, IL). Results were crosstabulated to find out the relationships between the variables. Statistical analysis was performed using χ 2 -square for test of association and Fisher's exact test as appropriate. A p-value of less than 0.05 was considered significant in all statistical analysis.
Result
Standard deviation (SD) of age in group I and group II patients were respectively 55.57±9.601 and 55.47±8.224 years. No significant difference was observed between two groups (0.428). In group-I patients 93.33 percent was male and rest was female. In group-II 73.30 percent patients was male and rest was female. No statistically significant difference was found between the group of patients p=0.531.
Twenty three (76.7%) patients of group-I and twenty four (80%) patients of group-II had hypertension. There was no statistically significant difference in hypertension between the two groups (p=0.120).Twenty five (83.3%) patients of group-I and twenty four (80%) patients of group-II had dyslipidaemia. There was no statistically significant difference in dyslipidemia between the groups (p=0.254). Nineteen (63.3%) patients of group-I and twenty five (83.3%) patients of group-II had positive family history of IHD. Statistically significant difference was observed both the two groups (p=0.003). Regarding the obesity no significant difference was observed (Table-1). 
Discussion
During the 20th century, use of tobacco products contributed to the deaths of 100 million persons worldwide. 1 In 2011, approximately 6 million additional deaths were linked to tobacco use, the world's leading underlying cause of death, responsible for more deaths each year than human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), tuberculosis, and malaria combined. 1 One third to one half of lifetime users die from tobacco products, and smokers die an average of 14 years earlier than nonsmokers. 27 Tobacco use also is a major risk factor for peripheral arterial disease. PAD is a condition in which plaque builds up in the arteries that carry blood to the head, organs, and limbs. People who have PAD are at increased risk for heart disease, heart attack, and stroke. According to the Centers for Disease Control and Prevention, around 8 million people in the US suffer from PAD, with between 12-20% of these aged 60 and over. But researchers from the UK and US have revealed that the number of people with peripheral artery disease worldwide has risen by 23.5% in the past 10 years, from 164 million in 2000, to 202 million in 2010. The mean age of studied patients was 56.63±8.95 years. Mean age difference was not statistically significant (p=0. 428). Nearly similar pattern of age distribution was reported by Sharmistha Sarangi, et al. 28 in their study in India. This observation was being consistent with the findings of different studies done in foreign countries. 29, 30, 31, 32 In this present study, there were 93.33% male in group I and 73.33% in group II with no significant difference in gender between the two groups (p=0.531). So the two groups were age and sex matched. In Asia the various studies showed the female patients formed a small percentage. [28] [29] [30] [31] [32] Except for higher prevalence of family history for ischemic heart disease in group I (p=0.003), other cardiovascular risk factors like hypertension (p=0.120), dyslipidemia (p=0.254) and obesity (0.093) were similarly in both group I and group II. The prevalence of risk factors in the present study was comparable with other studies. [28] [29] [30] [31] [32] ST elevation myocardial infarction (STEMI) was diagnosed in 26.7% in group I and 30% in group II. NSTEMI was diagnosed in 36.7% in group I and 46.7% in group II. Unstable angina was diagnosed in 36.7% and 23.3% in group I and group II, which is statistically significant between two group of patients (p=0.031). Similar statistical difference was found in Hasan A. Al Thani, et al.. 32 Coronary angiogram was done both group of patients, out of 60 patients 28(93.3%) patients of group I and 29(96.7%) patients of group II had coronary artery disease. No significant association was found between diabetic tobacco user and CAD severity (p=.500). 24.7% coronary artery disease was found in Sharmistha Saragi, et al.. 28 Twenty three patients of tobacco user group I (n=30) who had peripheral artery disease and ten patients of nonsmoker group II (n=30) had peripheral artery disease which is statistically significant (p=0.003). Gulf RACE (2009) was found statistical significant (p=0.001). 33 Out of 60 patients twenty three patients of group I and ten patients of group II had peripheral artery disease in this study which was statistically significant (p=0.001),OR for PAD when analyzed by univariate analysis adjusting for confounders like diabetes, family history of ischemic heart disease and tobacco use. DM with tobacco user group showed strong association with adjusted OR was 6.571 (CI 2.109-20.491). In this study total 33 patients had peripheral artery disease. 27 patients of age 46-65 years group had higher incidence than other groups which was not statistically significant, Shin Yi Jang et al. 29 was found similar prevalence but Sharmistha Sarangi, et al. 28 was found more prevalence of PAD in more than 65 years age group.16.7% patients of group I had femoral artery atherosclerosis and 10% patients of group II had femoral artery atherosclerosis, which was not statistically significant (p=0.433).13.3% and 23.3% patients of group I had popliteal and anterior tibial artery atherosclerosis but atherosclerosis of popliteal and anterior tibial artery was not found in group II patients. 33.3% patients of group I and 13.3% patients of group II had posterior tibial artery disease which was not statistically significant (p=0.593). 43.5% patients of group I and 23.3% patients of group II had arteria dorsalis pedis disease which was not statistically significant (p=0.089). 15 patients of 46-65 years age group had disease in ADP which was higher than other age group and was not statistically significant.
Conclusion
There is a definite and strong correlation between PAD and CAD. In view of the increasingly aging population and associated increase in atherosclerotic vascular disease, confrontation with patients of PAD will increase, which however, continues to be under diagnosed and under treated. The awareness and implementation of ABI in general clinical practice is poor. A simple, inexpensive test like ABI can improve the diagnosis of PAD in clinical practice and thus help in preventing CAD and consequent death by a range of medical therapies. A further study should be undertaken with larger sample size and involving multiple centers and longer duration of follow-up period will give clear picture of clinical outcome between peripheral artery disease and coronary artery disease among tobacco user diabetic patients.
